SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-084750
Filing Date
2024-04-02
Accepted
2024-04-02 16:06:58
Documents
2
Group Members
SUMITOMO PHARMA CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d801963dsc13ga.htm SC 13G/A 47860
2 EX-99.1 d801963dex991.htm EX-99.1 4092
  Complete submission text file 0001193125-24-084750.txt   53596
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-93291 | Film No.: 24814226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020
Business Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020 813-5201-0222
Sumitomo Chemical Co., Ltd. (Filed by) CIK: 0001798550 (see all company filings)

IRS No.: 980339148 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G/A